The cost of asthma medicines

3 April 2018 - Out-of-pocket cost is a major factor contributing to poor adherence to treatment, including in Australia where most ...

Read more →

Schedule of Pharmaceutical Benefits - 1 April 2018 update

1 April 2018 - The April 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 April 2018

1 April 2018 - The April 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Guilty: Health Department breached privacy laws publishing data of 2.5 million people

29 March 2018 - The federal Department of Health "unintentionally" breached privacy laws when it published de-identified health records of ...

Read more →

Agenda for 4 April TC meeting

29 March 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Decision to list eplerenone for the treatment of heart failure

29 March 2018 - PHARMAC is pleased to announce a decision to fund eplerenone (Inspra), subject to certain clinical criteria ...

Read more →

Adjustment of application fees for CADTH pharmaceutical reviews

28 March 2018 - In February 2018, CADTH announced that beginning in April 2018 application fees for CADTH pharmaceutical reviews ...

Read more →

Final NICE green light for Ipsen’s Cometriq

28 March 2018 - Ipsen’s Cometriq can now be routinely funded by the NHS to treat patients with medullary thyroid ...

Read more →

Legislation to make private health insurance simpler and more affordable

28 March 2018 - Legislation has been introduced into Parliament to deliver a wide ranging package of reforms to make private ...

Read more →

Parents take battle for life saving drug to Parliament

28 March 2018 - Six-year-old Violet Rickard sometimes asks her mother if she’s going to die. ...

Read more →

Gene therapy: international regulatory and health technology assessment activities and reimbursement status

28 March 2018 - There is widespread variation in the definition of gene therapy used by international regulatory bodies and a ...

Read more →

Revamp national cancer, mental health groups, panel tells minister

27 March 2018 - Dramatic overhaul urged to role of Ottawa and its arm's-length organizations in health care. ...

Read more →

Health consumer choice drives better care

27 March 2018 - Giving people greater choice in human services including health would give consumers more control over their ...

Read more →

Proposal to fund aflibercept and rivaroxaban

27 March 2018 - PHARMAC is seeking feedback on a proposal to list aflibercept (Eylea) and rivaroxaban (Xarelto) through a ...

Read more →

Young Canadians feeling the pinch of sky-high prescription drug prices

26 March 2018 - Use of Ontario’s public drug program has increased three fold since 2000, which suggests that young ...

Read more →